DexCom, Inc.DXCMNASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank93
3Y CAGR+8.7%
5Y CAGR+5.0%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
+8.7%/yr
Annual compound
5Y CAGR
+5.0%/yr
Recent acceleration
Percentile
P93
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 24.96% | +6.4% |
| 2024 | 23.45% | -7.3% |
| 2023 | 25.31% | +30.3% |
| 2022 | 19.43% | +26.0% |
| 2021 | 15.42% | -21.2% |
| 2020 | 19.56% | +35.4% |
| 2019 | 14.44% | +299.5% |
| 2018 | -7.24% | -164.1% |
| 2017 | -2.74% | +68.1% |
| 2016 | -8.58% | - |